JUNS

Jupiter Neurosciences Inc. Common Stock (JUNS)

Stock · NASDAQ · Health Care

$4.59as of 8/28/2026

Active signals

Support level
$0.283588
Industry
Biotechnology: Pharmaceutical Preparations

About JUNS

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$4.24M
P/E (trailing)
P/E (forward)
EPS (trailing)
$-14.56
Dividend yield
Beta
0.68
Avg. volume
52-week range
$4.56$138

How Jupiter Neurosciences Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$21.8KSG&A$6.84M (31381%)R&D$2.09M (9573%)Cost of Revenue$4.2K (19%)JUNS

Source: 10-K filed Apr 1, 2026 · via SEC EDGAR / Finnhub

Jupiter Neurosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • JUNS
    Jupiter Neurosciences Inc. Common Stock
    $4.59
    ▼ 6.13%
    Market cap $4.24MP/E
    $4.56$138
  • REVB
    Revelation Biosciences Inc. Common Stock
    $1.05
    ▲ 1.94%
    Market cap $4.38MP/E 0.04
    $0.875$11.72
  • DRMA
    Dermata Therapeutics Inc. Common Stock
    $1.49
    ▲ 1.71%
    Market cap $4.46MP/E
    $0.9509$6.23
  • INM
    InMed Pharmaceuticals Inc. Common Shares
    $1.43
    ▼ 0.35%
    Market cap $4.01MP/E
    $0.575$2.5
  • RNAZ
    TransCode Therapeutics Inc. Common Stock
    $2.18
    ▼ 4.39%
    Market cap $4.52MP/E
    $2.24$20.99
  • MBIO
    Mustang Bio Inc. Common Stock
    $0.5375
    ▼ 2.27%
    Market cap $3.87MP/E
    $0.525$1.85
  • SPRC
    SciSparc Ltd. Ordinary Shares
    $6.58
    ▲ 0.46%
    Market cap $3.85MP/E
    $2.98$80.1

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
4.54M
Disposed
0

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.